Clarendon Private’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
6,395
+98
+2% +$22.8K 1.04% 21
2026
Q1
$1.54M Buy
6,297
+698
+12% +$163K 1.18% 19
2025
Q4
$1.16M Buy
5,599
+1,407
+34% +$278K 0.98% 25
2025
Q3
$777K Buy
+4,192
New +$718K 0.71% 39
2025
Q2
Sell
-1,637
Closed -$272K 104
2025
Q1
$272K Sell
1,637
-271
-14% -$42.4K 0.29% 88
2024
Q4
$276K Buy
+1,908
New +$296K 0.29% 84

Other funds holding JNJ

Clarendon Private's JNJ Position: Q2 2026 in Review

Clarendon Private increased its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, buying an estimated $22.8K and bringing the position to 6,395 shares worth $1.62M. The position accounts for 1.04% of the portfolio, ranked #21.

Clarendon Private first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Clarendon Private held 6,395 shares of Johnson & Johnson worth $1.62M as of Q2 2026.
  • Clarendon Private bought 98 Johnson & Johnson shares in Q2 2026, an estimated $22.8K.
  • Johnson & Johnson made up 1.04% of Clarendon Private's portfolio in Q2 2026, its #21 holding.
  • Clarendon Private first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Clarendon Private's 13F filing for Q2 2026, filed 22 Jul 2026.